Insider · CIK 0001879378
William John Scheessele
officer
Files at HUMA (Humacyte, Inc.). First filing Apr 15, 2025, latest Apr 15, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$9,999 bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HUMA: Humacyte, Inc.
HUMAOct 9, 2026 · close 0.41
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 44Moderate | Humacyte, Inc. | $9,999 6,493 shares | +42% | +30% from low-76% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 14, 2025 | HUMA Humacyte, Inc. | POpen-market purchase Common Stock | +6,493 | $1.54 | $9,999 | 22,018 | Apr 15, 2025 |
| Jan 21, 2025 | HUMA Humacyte, Inc. | AGrant or award Stock Options (right to buy)derivative | +283,101 | $0.00 | $0 | 283,101 | Jan 23, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.